157 related articles for article (PubMed ID: 2669098)
1. Shigella vaccines.
Formal SB; Hale TL; Kapfer C
Rev Infect Dis; 1989; 11 Suppl 3():S547-51. PubMed ID: 2669098
[TBL] [Abstract][Full Text] [Related]
2. An update on Shigella vaccines.
Ashkenazi S; Cohen D
Isr J Med Sci; 1994; 30(5-6):495-7. PubMed ID: 8034510
[TBL] [Abstract][Full Text] [Related]
3. Strategies for development of potential candidate Shigella vaccines.
Lindberg AA; Pál T
Vaccine; 1993; 11(2):168-79. PubMed ID: 8438615
[TBL] [Abstract][Full Text] [Related]
4. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity.
Meitert T
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688
[No Abstract] [Full Text] [Related]
5. Pathogenesis, genetics of virulence, and immunity in Shigellosis.
Formal SB; Kapfer C; Hale TL
Kansenshogaku Zasshi; 1988 Mar; 62 Suppl():329-42. PubMed ID: 3138359
[No Abstract] [Full Text] [Related]
6. Pathogenesis and immunology in shigellosis: applications for vaccine development.
Hale TL; Keren DF
Curr Top Microbiol Immunol; 1992; 180():117-37. PubMed ID: 1380415
[No Abstract] [Full Text] [Related]
7. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K
Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732
[No Abstract] [Full Text] [Related]
8. Genetic determinants of virulence in Shigella and dysenteric strains of Escherichia coli: their involvement in the pathogenesis of dysentery.
Kopecko DJ; Baron LS; Buysse J
Curr Top Microbiol Immunol; 1985; 118():71-95. PubMed ID: 2414072
[No Abstract] [Full Text] [Related]
9. An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines.
Levine MM; Rice PA; Gangarosa EJ; Morris GK; Snyder MJ; Formal SB; Wells JG; Gemski P; Hammond J
Am J Epidemiol; 1974 Jan; 99(1):30-6. PubMed ID: 4590191
[No Abstract] [Full Text] [Related]
10. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
11. Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell-Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae.
Nag D; Koley H; Sinha R; Mukherjee P; Sarkar C; Withey JH; Gachhui R
Scand J Immunol; 2016 Feb; 83(2):92-101. PubMed ID: 26478541
[TBL] [Abstract][Full Text] [Related]
12. Genetics of virulence in Shigella.
Hale TL; Formal SB
Microb Pathog; 1986 Dec; 1(6):511-8. PubMed ID: 3334157
[No Abstract] [Full Text] [Related]
13. Current aspects of Shigella pathogenesis.
Torres AG
Rev Latinoam Microbiol; 2004; 46(3-4):89-97. PubMed ID: 17061529
[TBL] [Abstract][Full Text] [Related]
14. An attenuated Shigella mutant lacking the RNA-binding protein Hfq provides cross-protection against Shigella strains of broad serotype.
Mitobe J; Sinha R; Mitra S; Nag D; Saito N; Shimuta K; Koizumi N; Koley H
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005728. PubMed ID: 28727722
[TBL] [Abstract][Full Text] [Related]
15. Oral shigella vaccines.
Hale TL; Formal SB
Curr Top Microbiol Immunol; 1989; 146():205-11. PubMed ID: 2659269
[No Abstract] [Full Text] [Related]
16. Shigella vaccine development: prospective animal models and current status.
Kim YJ; Yeo SG; Park JH; Ko HJ
Curr Pharm Biotechnol; 2013; 14(10):903-12. PubMed ID: 24372251
[TBL] [Abstract][Full Text] [Related]
17. Immunity in shigellosis. I. Response of man to attenuated strains of Shigella.
DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
J Infect Dis; 1972 Jan; 125(1):5-11. PubMed ID: 4550417
[No Abstract] [Full Text] [Related]
18. Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path?
Phalipon A; Mulard LA; Sansonetti PJ
Microbes Infect; 2008 Jul; 10(9):1057-62. PubMed ID: 18672087
[TBL] [Abstract][Full Text] [Related]
19. Development and administration of live Shigella vaccines.
Pencu E
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):231-50. PubMed ID: 6443689
[No Abstract] [Full Text] [Related]
20. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
Phalipon A; Sansonetti P
Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
